Specialty Enzymes: Market Research Report

January 2015 | 322 pages | ID: S4E13815747EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Specialty Enzymes in US$ Million by the following Product Segments: Proteases, Polymerases, Carbohydrases, and Other Specialty Enzymes. The report is also analyzed by the following End-Use Applications: Pharmaceutical & Diagnostics, Research/ Biotechnology, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 41 companies including many key and niche players such as -

• Advanced Enzymes Technologies Limited
• Affymetrix, Inc.
• Amano Enzyme, Inc.
• Biocatalysts Ltd.
• BBI Solutions

Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Product Segments
Proteases
Polymerases
Carbohydrases
Other Specialty Enzymes
End-Use Segments
Pharmaceutical & Diagnostics
Research/Biotechnology
Other End-Uses

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

Specialty Enzymes: Indispensable to the Pharmaceutical Industry

Table 1. Global Market for Pharmaceutical/Diagnostics Enzymes by Application (2015E): Percentage Breakdown for Diagnostics, Digestive, Enzyme Replacement Therapy, Thrombolytic, and Others (includes corresponding Graph/Chart)

Outlook
Developed Regions Dominate Global Demand

Table 2. Global Market for Specialty Enzymes by Geographic Region/Country (2015E): Percentage Breakdown of Value Sales for Asia-Pacific, Canada, Europe, Japan, Latin America, the US, and Rest of World (includes corresponding Graph/Chart)

Table 3. Healthcare Spending as a Percentage of GDP by Geographic Region - North America, Western Europe, Latin America, Eastern Europe, Asia, and Middle East & Africa: 2015E (includes corresponding Graph/Chart)

Table 4. Per-Capita Healthcare Expenditure in Select Regions - The US, EU, Asia, and China: 2014E (includes corresponding Graph/Chart)

2. MARKET TRENDS, ISSUES AND DRIVERS

Robust Demand from the Pharmaceutical Industry: A Strong Growth Driver

Table 5. Global Market for Pharmaceuticals by Medication Class (2014): Percentage Breakdown of Value Sales for Anti-Infectives, Biologicals, Cardiovascular Drugs, Central Nervous System Drugs, Dermatological Agents, Gastrointestinal Agents, Hormones and Metabolic Agents, Nutritional Preparations, Ophthalmic Agents, Respiration Medications, and Other Medications (includes corresponding Graph/Chart)

Pharmaceutical Medication Class and Respective Growth Drivers
Some Important Specialty Enzymes and their Therapeutic Uses
Nattokinase Lowers Risk of Blood Clots
Seaprose-S: Effective in Break-up of Mucus
Papain and Bromelain: Anti-Inflammatory Agents
Serratiopeptidase: Anti-Inflammation and Analgesic Agent
Some Important Therapeutic Enzymes and their Source
Sources of Therapeutic Enzymes by Type: Listing of Source and Enzyme Derived for Animal Sources, Plant Sources, and Microbial Sources
Specialty Enzymes Reduce Pharmaceutical Production Costs
Rising Prominence in Disease Diagnosis Expands Market Opportunities
Focus on Preventive Medicine Spurs Growth in the Diagnostic Enzymes Market
Expanding Home Glucose Testing Market Bodes Well for Enzymes in Diagnostic Applications
Increasing Diabetes Incidence Worldwide: Key Opportunity Indicator

Table 6. Global Diabetes Mellitus Incidence among Ages 20-79 (2014E & 2035P): Prevalence (in Millions) and Percentage Share by Geographic Region (includes corresponding Graph/Chart)

Specialty Enzyme Advancements: Spearheading Growth
University of Pittsburgh Discovers the First Halogenations Enzyme
Growing Significance of Systemic Enzymes in Human Health Strengthens Market Prospects
Systemic Enzymes Aids in Effective Pain and Inflammation Management
Serrapeptase Enzyme: An Anti-Edemic and Anti-Inflammatory Agent
EXCLZYME: An Apt Replacement for NSAIDS?
Systemic Enzyme Therapy Relieve Painful Effects of Cancer Therapies
Systemic Enzymes for Nutritional Support throughout the Body
Regenerative Medicine: A Niche Market Beckons
Increasing Consumption in Health Supplements Augurs Well for the Market
Rising Adoption of Enzyme Supplements Spurs Product Innovation
Spiraling Healthcare Costs: An Important Opportunity Indicator for Supplemental Enzymes
Role of Specialty Enzymes in Supporting Cardiovascular Health Boosts Market Prospects
Cardiovascular Disease (CVD) Facts and Figures
Key CVD Statistics

Table 7. Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart)

Table 8. Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart)

Specialty Enzymes in Alzheimer’s, Parkinson’s, and Cancer Therapies Benefit Market Expansion
Cancer Cases: Important Opportunity Indicator

Table 9. Worldwide Incidence of Cancer (2013, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart)

Table 10. World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported in Thousands for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)

Enzyme Replacement Therapies for Lysosomal Storage Diseases (LSDs) Holds Promise
Aging Population Spurs Demand for Pharmaceutical and Diagnostic Enzymes

Table 11. Global Population Statistics for the 65+ Age Group (2013) (includes corresponding Graph/Chart)

Table 12. Global Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)

Specialty Enzyme as Biocatalysts in the Manufacture of Drugs and Fine Chemicals
Focus on Green Manufacturing Processes Drive Demand for Biocatalysts
Advancements in Enzyme Manufacturing Processes Aids Growth
Immobilization of Enzymes Opens up a World of Opportunities
European Food Enzymes Industry Shifts Focus towards Specialty Enzymes from Commodity Enzymes
Strong Research Activity Bodes Well for Research and Biotechnology Enzymes
Surging Demand for Eco-Friendly Enzymes Spurs R&D
Developing Countries: Potential Laden Markets

Table 13. Global Specialty Enzymes Market - Geographic Regions Ranked by CAGR for 2014-2020: Asia-Pacific, Latin America, the US, Canada, Europe, Japan, and Rest of World (includes corresponding Graph/Chart)

Manufacturers in Developed Countries Move Production Base to Developing Markets
Alkaline Phosphatase (ALP): A Key Diagnostic & Research Enzyme
Diagnostics
As a Diagnostic Enzyme in the Dairy Industry
Research
Regulatory Issues to Ensure Safety of Enzyme Usage
CRN & ETA Issue Guideline for Enzyme Supplements

3. PRODUCT OVERVIEW

Enzymes: An Introduction
A Brief History
Categorization of Enzymes
Advantages of Enzymes over Chemical Catalysts
Classification of Enzymes Based on Application
Industrial Enzymes
Specialty Enzymes
Proteases
Polymerases
Carbohydrases
Other Specialty Enzymes
Nucleases
Lipases
Catalases
Oxidase
Laccases
Phytases

4. PRODUCT INTRODUCTIONS/INNOVATIONS

GingisKHAN, a New Enzyme Product, Launched by Genovis AB
BioMarin Secures FDA Approval for VimiZim
Specialty Enzymes Unveils FlavorSEB L Enzyme Series for Pet Food Processing
Enzymedica Unveils Digest Gold with ATProacents
Deerland Enzymes Unveils New Enzyme-based Technologies
Sekisui Enzymes Introduces New Thermostable Enzyme Range
Codexis Launches Improved CodeXyme
Deerland Enzymes Introduces New ThioZymeYD Dietary Supplement
Sekisui Enzymes Introduces New ?-Lactamase Enzyme

5. RECENT INDUSTRY ACTIVITY

Novozymes and China National Pharmaceutical Foreign Trade Enter Distribution Deal
GSK & Codexis Enter Technology Licensing Agreement
Connell Brothers Takes Over Enzyme Solutions
Codexis Enters Product Development Deal with Purolite
Sekisui Diagnostics Announces New Headquarters in Massachusetts
Specialty Enzymes Expands Enzyme Products Manufacturing Capacity
Cornerstone Therapeutics Inks Agreement with Digestive Care
Codexis Extends Process and Catalyst Development Agreement with Merck
GENETRIX Inks Licensing Agreement with QIAGEN
Anil Bioplus to Establish Production Unit at Halol

6. FOCUS ON SELECT GLOBAL PLAYERS

Advanced Enzymes Technologies Limited (India)
Advanced Vital Enzymes Ltd. (India)
AST Enzymes (US)
Specialty Enzymes & Biotechnologies Co. (US)
Affymetrix, Inc. (US)
Amano Enzyme, Inc. (Japan)
Biocatalysts Ltd. (UK)
BBI Solutions (UK)
Chr. Hansen A/S (Denmark)
Codexis, Inc. (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Genzyme Corporation (US)
Life Technologies (US)
Meteoric Life Sciences (India)
Nagase & Co. Ltd (Japan)
National Enzyme Company (US)
The Soufflet Group (France)

7. GLOBAL MARKET PERSPECTIVE

Table 14. World Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 15. World Historic Review for Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 16. World 14-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Specialty Enzymes Market by Product Segment

Table 17. World Recent Past, Current & Future Analysis for Proteases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 18. World Historic Review for Proteases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 19. World 14-Year Perspective for Proteases by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 20. World Recent Past, Current & Future Analysis for Polymerases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 21. World Historic Review for Polymerases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 22. World 14-Year Perspective for Polymerases by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 23. World Recent Past, Current & Future Analysis for Carbohydrases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 24. World Historic Review for Carbohydrases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 25. World 14-Year Perspective for Carbohydrases by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 26. World Recent Past, Current & Future Analysis for Other Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 27. World Historic Review for Other Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 28. World 14-Year Perspective for Other Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Specialty Enzymes Market by End-Use Segment

Table 29. World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 30. World Historic Review for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 31. World 14-Year Perspective for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 32. World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 33. World Historic Review for Specialty Enzymes Consumption in Research/ Biotechnology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 34. World 14-Year Perspective for Specialty Enzymes Consumption in Research/ Biotechnology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 35. World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 36. World Historic Review for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 37. World 14-Year Perspective for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
Current and Future Analysis
Specialty Enzymes Market Overview
Specialty and Industrial Enzymes: Gradual Narrowing of Differences
Discovery of the First Halogenations Enzyme: Market Implications
Enzymes for Food Analysis and Testing: Key Challenges Faced
Aging Population Spurs Demand for Therapeutic and Diagnostic Enzymes

Table 38. North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)

CRN & ETA Issue Guideline for Enzyme Supplements
Product Launches
Recent Industry Activity
Key Players
B. Market Analytics

Table 39. US Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 40. US Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 41. US 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 42. US Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 43. US Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 44. US 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA

A. Market Analysis
Current and Future Analysis
B. Market Analytics

Table 45. Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 46. Canadian Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 47. Canadian 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 48. Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 49. Canadian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 50. Canadian 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

A. Market Analysis
Current and Future Analysis
Expanding Aging Population Offers Opportunities for Pharmaceutical Enzymes

Table 51. Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart)

Key Players
B. Market Analytics

Table 52. Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 53. Japanese Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 54. Japanese 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 55. Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 56. Japanese Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 57. Japanese 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

A. Market Analysis
Current and Future Analysis
Accelerating Trend towards Environmentally Friendly Enzymes
Enzymes for Research and Biotechnology to Report Faster Gains
European Food Enzymes Industry Shifts Focus towards Specialty Enzymes from Commodity Enzymes
Aging Population Boosts Demand for Pharmaceutical and Diagnostic Enzymes

Table 58. European Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)

Table 59. European Country-wise Statistics of 60+ Population as % of Total Population: 2013 (includes corresponding Graph/Chart)

B. Market Analytics

Table 60. European Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 61. European Historic Review for Specialty Enzymes by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 62. European 14-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 63. European Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 64. European Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 65. European 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 66. European Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 67. European Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 68. European 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4A. FRANCE

A. Market Analysis
Current and Future Analysis
The Soufflet Group – A Key Regional Player
B. Market Analytics

Table 69. French Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 70. French Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 71. French 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 72. French Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 73. French Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 74. French 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4B. GERMANY

A. Market Analysis
Current and Future Analysis
B. Market Analytics

Table 75. German Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 76. German Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 77. German 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 78. German Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 79. German Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 80. German 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4C. ITALY

A. Market Analysis
Current and Future Analysis
B. Market Analytics

Table 81. Italian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 82. Italian Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 83. Italian 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 84. Italian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 85. Italian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 86. Italian 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4D. THE UNITED KINGDOM

A. Market Analysis
Current and Future Analysis
Product Launches
Key Players
B. Market Analytics

Table 87. UK Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 88. UK Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 89. UK 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 90. UK Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 91. UK Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 92. UK 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4E. SPAIN

A. Market Analysis
Current and Future Analysis
Recent Industry Activity
B. Market Analytics

Table 93. Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 94. Spanish Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 95. Spanish 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 96. Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 97. Spanish Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 98. Spanish 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4F. RUSSIA

A. Market Analysis
Current and Future Analysis
B. Market Analytics

Table 99. Russian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 100. Russian Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 101. Russian 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 102. Russian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 103. Russian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 104. Russian 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4G. REST OF EUROPE

A. Market Analysis
Current and Future Analysis
Product Launch
Key Players
B. Market Analytics

Table 105. Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 106. Rest of Europe Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 107. Rest of Europe 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 108. Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 109. Rest of Europe Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 110. Rest of Europe 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A. Market Analysis
Current and Future Analysis
Specialty Enzymes at Par with Industrial Enzymes in APAC
Asian Countries: Strong Markets with Huge Untapped Potential

Table 111. Global Market for Specialty Enzymes (2014-2020): Ranked by CAGR for Asia-Pacific, Latin America, US, Canada, Europe, Japan, and Rest of World (includes corresponding Graph/Chart)

Table 112. Asian Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)

India & China: Potential Laden Markets for Pharma and Diagnostic Enzymes

Table 113. China and India Lead Global Population (July 2013): China and India’s Huge Population Vis-a-vis Other Countries’ Population (in Million) by Age Group (includes corresponding Graph/Chart)

Manufacturers in Developed Countries Move Production Base to Developing Markets
B. Market Analytics

Table 114. Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - China, India, South Korea and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 115. Asia-Pacific Historic Review for Specialty Enzymes by Geographic Region - China, India, South Korea and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 116. Asia-Pacific 14-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for China, India, South Korea and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 117. Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 118. Asia-Pacific Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 119. Asia-Pacific 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 120. Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 121. Asia-Pacific Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 122. Asia-Pacific 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5A. CHINA

A. Market Analysis
Current and Future Analysis
Chinese Enzyme Demand by End-Use

Table 123. Chinese Enzyme Market by End-Use Sector (2014): Percentage Breakdown of Value Sales for Industrial (Animal Feed, Cleaning Products, Ethanol Production, Food & Beverage, and Other Industrial) and Specialty (includes corresponding Graph/Chart)

Enzyme Demand by Enzyme Type

Table 124. Chinese Enzyme Market by Type (2014): Percentage Breakdown of Value Sales for Carbohydrases (Amylases and Other Carbohydrases), Lipases, Polymerases & Nucleases, Proteases, and Other Enzymes (includes corresponding Graph/Chart)

Strategic Corporate Development
B. Market Analytics

Table 125. Chinese Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 126. Chinese Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 127. Chinese 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 128. Chinese Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 129. Chinese Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 130. Chinese 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5B. INDIA

A. Market Analysis
Current and Future Analysis
India: One of the Fastest Growing Enzymes Market
Recent Industry Activity
Key Players
B. Market Analytics

Table 131. Indian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 132. Indian Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 133. Indian 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 134. Indian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 135. Indian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 136. Indian 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5C. SOUTH KOREA

A. Market Analysis
Current and Future Analysis
B. Market Analytics

Table 137. South Korean Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 138. South Korean Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 139. South Korean 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 140. South Korean Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 141. South Korean Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 142. South Korean 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5D. REST OF ASIA-PACIFIC

A. Market Analysis
Current and Future Analysis
Strategic Corporate Development
B. Market Analytics

Table 143. Rest of Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 144. Rest of Asia-Pacific Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 145. Rest of Asia-Pacific 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 146. Rest of Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 147. Rest of Asia-Pacific Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 148. Rest of Asia-Pacific 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

A. Market Analysis
Current and Future Analysis
B. Market Analytics

Table 149. Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 150. Latin American Historic Review for Specialty Enzymes by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 151. Latin American 14-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin American Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 152. Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 153. Latin American Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 154. Latin American 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 155. Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 156. Latin American Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 157. Latin American 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6A. BRAZIL

A. Market Analysis
Current and Future Analysis
B. Market Analytics

Table 158. Brazilian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 159. Brazilian Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 160. Brazilian 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 161. Brazilian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 162. Brazilian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 163. Brazilian 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6B. REST OF LATIN AMERICA

A. Market Analysis
Current and Future Analysis
B. Market Analytics

Table 164. Rest of Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 165. Rest of Latin American Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 166. Rest of Latin American 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 167. Rest of Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 168. Rest of Latin American Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 169. Rest of Latin American 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

A. Market Analysis
Current and Future Analysis
B. Market Analytics

Table 170. Rest of the World Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 171. Rest of the World Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 172. Rest of the World 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 173. Rest of the World Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 174. Rest of the World Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 175. Rest of the World 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 41 (including Divisions/Subsidiaries - 45)
The United States (22)
Canada (1)
Japan (4)
Europe (10)
  France (1)
  Germany (2)
  The United Kingdom (2)
  Spain (1)
  Rest of Europe (4)
Asia-Pacific (Excluding Japan) (8)